Atrophic gastritis (AG) and intestinal metaplasia (IM) are the main precursor lesions of gastric cancer as the incidence of gastric cancer increases in the gastric mucosa involved with AG and IM. The prevalence of AG and IM vary depending on countries, even it represents diverse results in the same nation. Usually AG is antecedent of IM but the etiologies of AG and IM are not always the same. The sensitivity and specificity of diagnostic methods to detect AG and IM are different. Furthermore, the management strategy of AG and IM has not been established, yet. Helicobacter pylori infection has been proved as the most important cause of AG and IM. Thus the eradication of H. pylori is very important to prevent the progression to gastric cancer which is still placed in the high rank in morbidity and mortality among cancers. However, the reversibility of AG and IM by eradication of H. pylori which was assumed to be certain by meta-analysis is; however, controversial now. Therefore, the understanding and early diagnosis of AG and IM are very important, especially, in high incidence area of gastric cancer such as Republic of Korea. 
INTRODUCTION
Gastric cancer remains the second most frequent cause of cancer-related deaths and ranks 4th in cancer incidence worldwide. 1 In Republic of Korea, gastric cancer is the second most common cancer followed by thyroid cancer and the third cause of cancer-related death followed by lung and liver cancer in the database of 2013. 2 The prognosis of gastric cancer varies depending on stages. The 5-year survival rates for advanced gastric cancer are less than 20%. On the contrary, early gastric cancer (EGC) makes a good prognosis that the 5-year survival rates are over 90% to 95%. [3] [4] [5] Therefore, it is important to individualize the management for high risk group of gastric cancer. The risk factors of gastric cancer are Helicobacter pylori infection, salt intake, smoking, alcohol, family history of gastric cancer, atrophic gastritis (AG), and intestinal metaplasia (IM). 6 Particularly AG and IM are considered to be premalignant lesions of gastric cancer. 6 For this reason effective diagnosis and management of AG and IM is a very important research topic to prevent gastric cancer. [7] [8] [9] According to a recent meta-analysis, the incidence rates of AG are in a wide range from 0% to 10.9% per year. 10 This wide range of incidence of AG could be explained by the different settings in which the diagnoses of AG were made. 10 H. pylori infection is the most important risk factor of AG and IM. AG is considered to be an antecedent to IM. 11 Thus the risk factors for AG are expected to be similar to those for IM. However, bacterial factors have been found to play an important role for AG while environmental and host factors are more important for IM. 11 From this background, the aim of this review is to provide comprehensive information regarding the epidemiology, etiology, diagnosis and management of AG and IM, which will lay a foundation to establish strategies to prevent gastric cancer. Gastritis begins from superficial gastritis and progresses into atrophic gastritis, metaplasia, dysplasia and gastric cancer. Adapted from Correa et al. were observed before the identification of H. pylori infection in 1982. 21 Gastric cancer divides into 2 major histologic types,
intestinal-type and diffuse-type, by Lauren classification. 22 The intestinal-type cancers are believed to arise secondary to AG and IM. 23 On the contrary, diffuse-type gastric cancer usually arises independently of IM. This raised doubts about the association between IM and gastric cancer development. 24 It is thought that diffuse type is more likely to have a primary genetic etiology, and the involvement of H. pylori is probably limited to a subset of sporadic cases. 23, 24 However, many studies suggest that both intestinal and diffuse types of gastric carcinoma are associated with H. pylori infection. 25, 26 Compared with other risk factors of gastric cancer, AG and IM increase the risk of intestinal type gastric cancer exponentially. The risk of gastric cancer in subjects with severe fundal AG was 5.76 times higher than that in those having little or no fundal AG. 27 In addition, the subjects with IM have more than a 10-fold increased risk of developing gastric cancer. 28 In addition, several groups have reported the correlation between H. pylori infection and gastric cancer. Moreover AG and IM, precursors of gastric cancer, elevate the risk of gastric cancer. 18, 19 In a prospective study of 1,526 subjects, 18 In a cohort study of 2,224 subjects conducted in Republic of Korea, the group with IM have 10.9-fold increased risk of gastric cancer. 20 Therefore, each lesion of AG or IM will increase the incidence of gastric cancer, and if both lesions are combined, the incidence of gastric cancer will increase even more. 36 And tumor necrosis factor alpha from plays major roles in the growth, invasion and metastasis of neoplasm. This mechanism was called 'a perigenetic pathway'. 36 Another study suggested that the TNF-α inducing protein (Tipα) from H. pylori binds to and enters the nucleus through a specific biding molecule, act as a carcinogen of gastric cancer.
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PREVALENCE OF ATROPHIC GASTRITIS AND INTESTINAL METAPLASIA
A meta-analysis of 14 studies on incidence of AG was reported in 2010, 10 of which the incidence rates of AG ranged from 0% to 10.9% per year. 10 This wide range of incidence is explained by the particular settings in which the diagnosis of AG was made. 10 The lowest incidence rates (0%) were found in patients with reflux esophagitis and in patients successfully treated for H. pylori infection. 38, 39 The highest incidence rate (10.9%) was observed in a study conducted in patients who underwent vagotomy for ulcer disease. 42 The prevalence of AG and IM increases significantly with age for both men and women. 42 A multicenter study of Republic of Korea in 2006, with 25,536 asymptomatic subjects assigned, evaluated that the prevalences of endoscopic AG and IM were 27.1% and 7.1%, which were lower than those estimated with histologic diagnoses. 43 The proportions of AG and IM in patients aged 40 years or less were 14.9% and 2.7%, and in those aged 60 years or more were 43.5% and 12.3%. This study showed that the prevalence of AG and IM increased significantly with age and male. 43 The prevalences of endoscopic AG and IM were 40.7% and 12.5% in a multicenter study of 4,023 subjects in 2011, significantly higher than those of a multicenter study in 2006. 44 In addition, the prevalences of AG and IM in males were still higher than those in females. 44 This increase in prevalence of AG and IM may be attributed to aggressive diagnosis made by physicians in 2011 relative to 2006 rather than the real increase of prevalence rate of AG and IM. 44 The prevalence of AG and IM varies (9.4% to 63.8% in case of AG; 7.1% to 42.5% in case of IM) depending on diagnostic methods and countries (Table 1) .
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RISK FACTORS OF ATROPHIC GASTRITS AND INTESTINAL METAPLASIA
Several studies have investigated that dietary causes such as excessive salt intake, deficient ascorbic acid, and insufficient carotene could be risk factors of AG, IM, and gastric cancer. 15, 51 However, among the many risk factors, H. pylori infection is considered as the most important risk factor of AG and IM. [18] [19] [20] 32 Especially, bacterial virulence genes such as cagA and VacA were found to be important risk factors of AG, IM, and gastric cancer. [52] [53] [54] [55] [56] In a study of 58 subjects of H. pylori infection, with a mean follow-up period of 11.5 years, cagA was associated with a significantly increased risk of AG and IM (OR, 3.48; 95% CI, 1.02 to 12.18). 53 Infection with cagA-positive strains further increased the risk for gastric cancer by 1.64 (95% CI, 1.21 to 2.24) overall in a meta-analysis. 54 cagA proteins secreted by H. pylori translocate into cytoplasm of gastric mucosa cells via its type IV secretion system after H. pylori attachment. The cagA can interrupt signaling pathways by phosphorylation-dependent and independent mechanisms, leading to cytoskeletal change, motility, and abnormal proliferation in normal gastric epithelial cells. 35 VacA is another well-known virulence factor, s1 and m1 forms of VacA are more common in disease-associated H. pylori strains, and s1m1 genotype was related to gastric epithelial damage, AG and IM. 52 America. Given the geographic distribution of specific H. pylori genotypes, it could be speculated that there might be differences in incidence of gastric cancer. [58] [59] [60] 
CLASSIFICATION OF GASTRITIS AND INTESTINAL METAPLASIA
There is no universally accepted classification of gastritis, although several classifications of gastritis have been proposed. The first classification based on histopathological examination of gastric mucosa collected by so-called blind biopsies and samples collected during surgical procedures was created by Schindler. 61 Schindler 61 described that gastritis was divided into a superficial gastritis (Fig. 2B ) that may progress to AG (Fig. 2C) and IM ( Fig. 2D ) with time, which is different from normal ( Fig. 2A) . Additionally, Schindler 61 proposed that there were different courses and prognoses of disease by the type of the gastritis. And a novel classification and grading of gastritis was devised by a group of experts at the 9th World Congress of Gastroenterology in Sydney, Australia in 1990. 62 The histological division of Sydney System is a practical guideline upon which the morphological features of gastritis in endoscopic biopsy samples should be documented. Type, severity and extent of gastric inflammation composed to possible etiology should be detailed depending on the chart. The Sydney System asserted the routine gastric biopsy sampling protocol (two from antrum and two from corpus, both from anterior and posterior walls) and sample fixation in adequately labelled separate containers. 62 Now the updated Sydney system in 1996 is most widely used as the classification of gastritis. 63 The original Sydney classification of gastritis dividing into gastritis acute, chronic and special forms, and grading of chronic inflammation, neutrophil activity, atrophy, IM and H. pylori density into mild, moderate and marked categories were kept. 62 The updated Sydney system introduced a visual analogue scale for evaluating the severity of histological grading (Fig. 3) . 63 The histological features of the gastric mucosa were recorded using updated Sydney system scores, that is, 0 = none, 1 = mild, 2 = moderate, and 3 = marked. 63 It changed the routine of endoscopic biopsy sampling by the introduction of biopsy sampling from the incisura angularis and modified corpus and antrum biopsy locations from the two opposite walls in lesser and greater curvature of both parts (Fig. 4) . 63 Endoscopic description of acute gastritis by Sydney system are divided into edema, exudates, erosions and hemorrhage. In contrast, endoscopic diagnosis and classification of chronic gastritis are reliable depending on the inter-observer. 63 The updated Sydney system is the most widely used classification of gastritis. However, it does not reflect prognosis of gastric cancer risk in subjects with CAG. Therefore, the Operative Link on Gastritis Assessment (OLGA) was developed to improve the histological staging system for gastric atrophy. 64 OLGA system uses gastric biopsy sampling protocol defined by Sydney System and the histological grading system recommended by the updated Sydney System (Fig. 5) . 64 Long-term follow-up studies with follow-up ranges from 144 to 204 months proved that the OLGA staging reflects relevant information on clinic-pathological outcome of gastritis and therefore H. pylori negative patients with low OLGA stages could be excluded from secondary preventive surveillance of gastric cancer. 65 Whereas patients with higher OLGA stages (Stages III and IV) should be considered definitely candidates for endoscopic examination. 65 71 However, a recent systemic review concluded that the incomplete IM was significantly related to the prevalence of gastric cancer. Moreover, it reported that the relative risks of gastric cancer were from 4-to 11-fold higher for the presence of incomplete type in comparison to complete type or in comparison to the absence of incomplete type. This systemic report concluded that subtyping of IM have the scientific evidence on the evaluation of gastric cancer risk.
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DIAGNOSIS OF ATROPHIC GASTRITIS AND INTESTINAL METAPLASIA
In most of previous studies about the clinical relevance of Adapted from Kimura and Takemoto. 77 endoscopic and histologic diagnosis of the gastritis, the diagnosis of gastritis should have been based on histological examination of the gastric mucosa. 73, 74 Especially in the young age group, a high index of suspicion of gastric atrophy is important, and confirmation of the diagnosis by histology is necessary. 75 However in another study, endoscopic and histological diagnosis displayed high correlation. 76 Particularly, the benefits of upper endoscopy to conform atrophic change of gastric mucosa are generally acceptied. 77, 78 Endoscopic features of AG is the visibility of a vascular pattern of gastric mucosa (Fig. 2C ) than normal gastric mucosa ( Fig. 2A) . Gastric IM (Fig. 2D) is defined as the replacement of the surface, foveolar, and glandular epithelium in the oxyntic or antral mucosa by intestinal epithelium. The endoscopic finding of IM is observed as a mucosal nodular pattern, usually occuring after the occurrence of the AG. It is not difficult to diagnose severe cases of AG and IM properly by endoscopic findings, but it is difficult to make the diagnoses of mild AG and IM. 75 Sometimes endoscopic diagnosis is not correlated to histological diagnosis. Therefore, it is proper to biopsy in suspected cases of AG and IM. However, atrophic mucosal changes are not distributed similarly in whole gastric mucosa. So multiple endoscopic biopsy of gastric mucosa does not always represent AG. Furthermore, it is difficult to take multiple biopsies of all subjects with simple gastritis. 79, 80 To resolve this clinical difficulty, noninvasive tests for precursor lesions such as serum level of pepsinogen (PG), gastrin-17 and H. pylori immunoglobulin G antibodies could be used as biomarkers of AG and IM to replace endoscopic biopsy. 81 In the review, we discuss about three diagnostic methods for AG and IM; endoscopic, histological and PG I/II ratio.
Endoscopic diagnosis of atrophic gastritis and intestinal metaplasia
Endoscopic diagnosis of AG and IM is the basic method. However, there is the possibility of low sensitivity, specificity and inter-observer variation. Endoscopic diagnosis of AG is made when the visibility of a vascular pattern followed by loss of gastric mucosal gland is present (Fig. 2C) . There are various criteria to endoscopic classification of atrophic gastritis. AG due to H. pylori infection is more common in the east and atrophic mucosal change progresses from antrum to the corpus along with lesser curvature (Fig. 6C) , this endoscopic features reflect KimuraTakemoto classification well. 82 The boundaries of the mucosal atrophy is called the F line (Fig. 6B) , and AG is classified into six types. The closed-type AG indicates that the atrophic border remains on the lesser curvature, while the open-type AG means that the atrophic border no longer exists on the lesser curvature but extends along the anterior and posterior walls of the stomach (Fig. 6A) . However, Western physicians lack a good understanding of Kimura-Takemoto classification because the ratio of autoimmune gastritis is greater in the West than in the East and H. pylori infection rate is rather low. 83 In addition, the inter-observer reliability is rather low in Kimura-Takemoto classification from endoscopic features. Other limitation of the endoscopic diagnosis of AG and IM is the lower sensitivity and specificity than the pathological diagnosis. In the study of 1,333 subjects in Republic of Korea, the sensitivity of the prevalence of endoscopic diagnosis of atrophy was significantly low in age below 50 years old. 75 The sensitivity and specificity of endoscopy for the diagnosis of gastric atrophy based on histological findings were 61.5% and 57.7% in the antrum, and were 46.8% and 76.4% in the corpus of the stomach. Especially endoscopic diagnosis of AG was inaccurate below 50 years of age because of mild atrophic mucosal change may look normal in endoscopy. 75 In addition, the sensitivity and specificity of endoscopic IM diagnosis were also low in study by Lim et al. 84 The sensitivity and specificity of endoscopic diagnosis of IM based on histology were 24.0% and 91.9% for the antrum and were 24.2% and 88.0% for the corpus. As indicated by a multivariate analysis, the activity of mucosal inflammation and the presence of endoscopic AG were associated with the sensitivity of endoscopic diagnosis of IM in the antrum, while benign gastric ulcers, dysplasia, and the presence of endoscopic AG were associated with the sensitivity of endoscopic diagnosis of IM in the corpus. 84 Thus, a high level of suspicion is important to increase the sensitivity of endoscopic diagnoses of IM, especially when adenoma, endoscopic AG and ulcer are present, and confirmation of the doubt by histological diagnosis is necessary.
Other methods for endoscopic diagnosis of AG or IM are magnification chromoendoscopy and narrow band imaging (NBI). Several studies have suggested that chromoendoscopy with magnification could help to identify lesions of IM and dysplasia. 85 However, high resolution magnifying endoscopy without chromoendoscopy also appears superior to standard endoscopy, allowing great accuracy for the diagnosis of H. pylori gastritis, IM, and dysplasia. 86, 87 The recent technology of NBI has been found to have good sensitivity and specificity for the diagnosis of gastric precancerous lesions. 88, 89 However, there is no agreement on which NBI patterns are associated with gastric precancerous lesions. So, further study is needed to apply NBI in diagnosis of AG and IM.
Histological diagnosis of atrophic gastritis and intestinal metaplasia
The second method of diagnosis of AG is histopathology. The updated Sydney system is the most widely accepted for classification and grading of gastritis. The updated Sydney system recommended five biopsies, two from the antrum, one from the incisura, and two from the corpus, because atrophic mucosal change and IM of gastric mucosa progress from antrum to body (Fig. 3) . 63 If it is difficult to obtain at these three points, biopsies from antrum and corpus are recommended. It is desirable to examine specimens from antrum and corpus of lesser and greater curvature, yet there are practical difficulties. Clinically, one biopsy specimen from lesser curvature and the other from greater curvature are used to evaluate AG and IM. 73, 84, 90 Histological diagnosis is difficult when the specimens are inadequate. Deep portion of normal gastric mucosa are composed of different types of cells in antrum and body. Normal gastric mucosa of the antrum is composed of mucous glands which secrete gastric mucus, and that of the body is composed of parietal cell and chief cell which secrete gastric acid and digestive enzymes. Sometimes severe inflammation obscures the gland's population, making it impossible to assess mucosal atrophy reliably. Such cases can be labeled as 'indefinite for atrophy' and the final judgment can be deferred until the inflammation has regressed. In addition, the diagnosis of 'indefinite for atrophy' may be controversial among pathologists due to the difficulty in histological diagnosis. 91 IM is defined as the replacement of the surface, foveolar, and glandular epithelium in the oxyntic or antral mucosa by intestinal epithelium. These IM has been subtyped by classification of mucin expression. There are several classification systems for IM. The most widely used and useful classification is was made by Jass and 
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Complete type IM is similar to small intestine in pathologic features and tests positive for the MUC2 secreted by goblet cells. While, incomplete type IM is similar to large intestine in pathologic features, and positive for MUC5AC, MUC6 secreted by gastric mucosa and MUC2. 70, 93 In addition, high iron diaminealcian blue (HID-AB) stain can help classify the types of IM. Type I IM expresses only sialomucins (bright blue) ( Fig. 7 ; type I) and type II, III expresses sialomucins (bright blue) and sulfomucins (black) ( Fig. 7 ; type II and type III). 70 Jass and Filipe 92 reported that type III IM is associated with intestinal type gastric cancer. Other researchers have suggested that incomplete type IM is associated with gastric cancer. As such, it is still controversial discussing which type of IM is related with gastric carcinogenesis. 67, 68, 70 In a cohort study of 861 subjects conducted in Republic of Korea, type III IM was associated with aging (P = 0.036), and type II IM was associated with gastric carcinogenesis in the presence of H. pylori infection (P ＜ 0.05). 
Diagnosis by serum pepsinogen I/II ratio
The third diagnostic method of AG or IM is a measurement of serum PG I, II and I/II ratio. The radioimmunoassay method is used to measure serum PG levels. Recently, a new method has emerged to measure PG level. 94, 95 The present methods to measure PG level are Latex-enhanced Turbidimetric Immunoassay (HBi Corp., Seoul, Korea; imported from Shima Laboratories, Tokyo, Japan), 90, 94, 95 and enzyme-linked immunosorbent assays (Biohit ELISA kit; Biohit, Helsinki, Finland). 96, 97 PG has been used to screen AG, IM and gastric adenocarcinoma for more than 20 years because of its non-invasiveness and cost-effectiveness. In Japan, PG screening for gastric cancer has been used to improve population compliance. 98 However, PG screening is not accepted as a generalized screening method of AG or IM worldwide because of low positive predictive value in other countries. 99 PG I is produced by chief cells in antrum and corpus, while PG II is produced by the chief cells and mucous neck cells of the whole gastric mucosa. When gastric atrophy develops, chief cells are replaced by pyloric glands, leading to a decrease in PG I level, while PG II levels is relatively unaffected, so a low PG I/II ratio reflect the severity of AG. 100, 101 In a prospective study of 5,113 subjects in Japan, screening for gastric cancer with PG I ＜ 70 ng/mL and PG I/II ratio ＜ 3 as the cut-off points had the sensitivity and specificity of 84.6% and 73.5%, respectively.
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Generally PG I/II ratio 3.0 or less has been widely accepted as a cut-off value in several studies. 103 However, in a recent Korean study which evaluated the relationship between PG level and AG, a new cut-off value of PG I/II ratio, 3.2, was suggested to diagnose AG. 90 The study suggested that serum PG I/II ratio remarkably decreased in correlation with the extent of atrophy by the Kimura-Takemoto classification. 90 In another Korean research, PG I and PG II were negatively correlated with AG and only PG I/II ratio was positively correlated with AG. 95 Serum PG I and PG II were higher in H. pylori-positive than in H. pylori-negative subjects, because a growth rate of PG II was higher than that of PG I in H. pylori positive individuals. 90, 94, 95 Moreover, a significantly positive correlation was found between age and the PG II (P ＜ 0.001) and a negative correlation between age and the PG I/II ratio (P ＜ 0.001). No correlation was found between age and the PG I. Men had significantly higher PG I levels compared with women (P ＜ 0.001), and had a slightly higher PG II levels without statistical significance. These results suggest that the difference in the PG I levels observed between sex could be related to hormonal effects. 95 Consequently these results show that multiple factors could change the serum PG level. Thus, the proper cut-off value of PG level would be necessary in order to increase sensitivity and specificity.
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MANAGEMENT STRATEGY FOR ATROPHIC GASTRITIS AND INTESTINAL METAPLASIA
Up to the present time, there are no unified clinical guidelines for prevention of gastric cancer regarding the classification of high-risk groups progressing to gastric cancer. 104 However, through many studies, AG and IM are considered as precancerous lesions. Prevention and treatment of AG and IG could decrease the prevalence of gastric cancer. AG and IM could be managed by several strategies. H. pylori infection triggers a multistep progression from chronic gastritis, AG, IM and finally to invasive gastric cancer. 30 To reduce the prevalence of gastric cancer, H.
pylori eradication is a key step in management strategy. Another strategy is the surveillance to detect EGC in the subjects with AG 
Screening for early detection of gastric cancer
The 5-year survival rate of EGC was greater than 90%. 125 Moreover, surgery is no longer needed because of the recent advances in endoscopic resection techniques and technologies for EGC. 126 Therefore, it is important to establish optimal screening methods in high gastric cancer prevalence area such as Republic of Korea and Japan. Republic of Korea and Japan have been conducting biennial screening of gastric cancer in general population over 40-years-of-age. 127, 128 However, optimal screening interval of gastric cancer is still under discussion. In a Japanese study, the 5-year survival rate was significantly higher in subjects who had undergone endoscopic examinations within 2 years before being diagnosed with gastric cancer than that of patients who had not (96.5% vs. 71.0%; P ＜ 0.01).
were not significantly different (P = 0.4595). 129 These results have served as the basis for recommending that the optimal interval for screening of gastric cancer should be 2 years. Yet, optimal screening methods in high risk group of gastric cancer are still controversial. A recent Korean study in a subgroup of subjects with severe IM, EGC was more frequently observed in the 1-year interval screening group than the 2-year interval screening group (66.7% vs. 35.5%; P = 0.047). 130 Another Korean study conducted with the general population in a healthcare center reported that the proportion of EGC was higher in an annual screening group than in a biennial screening group (98.6% vs. 80.7%; P ＜ 0.01) and endoscopic resection was performed more frequently in the annual screening group (56.9% vs. 33.3%; P = 0.02). 131 This result also suggested that 1-year interval surveillance could be useful for high risk subjects with IM.
Control of other risk factors
Adequate consumption of vegetables and fruits seems to reduce the risk of cancer and decrease the incidence of gastric cancer in the West. Although some studies for premalignant gastric lesions have shown positive results of vitamin C, folic acid, and beta-carotene supplementation, though these results were not confirmed in a large meta-analysis. [132] [133] [134] [135] H. pylori eradication is the main strategy for prevention of gastric cancer in individuals with AG and IM, but it may be helpful to change diet and supply vitamin C, folic acid, and beta-carotene. Consequently, further large cohort study is needed to establish the optimal strategy of gastric cancer prevention.
CONCLUSION
Gastric cancer is still a major cause of death in Republic of Korea. To reduce the prevalence of gastric cancer, it is very important to classify and manage the high risk groups of gastric cancer. Furthermore, H. pylori infection triggers a multistep inflammation from chronic gastritis, atrophic gastritis, IM and finally to gastric cancer. Many studies have proved that AG and IM are precancerous lesions of gastric cancer. Diagnostic methods of AG and IM are endoscopic, histological findings and PG I/II ratio. Each method has advantages and disadvantages, and it is necessary to select the proper test according to the individual cases. As the infection of H. pylori is the most important risk factor of AG and IM it is important to perform H. pylori eradication to prevent the progression to gastric cancer. The appropriate time to prevent gastric cancer by H. pylori eradication is still under discussion. However, the most effective time point is before development of AG and IM. And it is difficult to know who will develop the AG and/or IM in the presence of H. pylori. H. pylori eradication had been known to improve AG histologically but not IM. However, a recent meta-analysis of IM after eradication of H. pylori reported the histological improvements even in cases of IM. In terms of early detection of gastric cancer 1-year interval of endoscopic screening for AG and IM could be superior in decreasing the prevalence of gastric cancer. Controlling other risk factors such as diet, vitamin C, beta-carotene and folic acid may be useful to decrease the prevalence of gastric cancer. However, further researches about the effect of H. pylori eradication, optimal screening interval and diet change, and various chemoprevention trials to prevent the development of gastric cancer are needed. 
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